QNTM vs. SMHX
QNTM (Quantum BioPharma Ltd) is a stock, while SMHX (VanEck Fabless Semiconductor ETF) is Semiconductors fund tracking the MarketVector™ US Listed Fabless Semiconductor Index. Over the past year, QNTM returned -66.38% vs 143.03% for SMHX. At a 0.16 correlation, their price movements are largely independent.
Performance
QNTM vs. SMHX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, QNTM achieves a -30.00% return, which is significantly lower than SMHX's 76.78% return.
QNTM
- 1D
- -2.67%
- 1M
- -7.93%
- YTD
- -30.00%
- 6M
- -47.32%
- 1Y
- -66.38%
- 3Y*
- -59.91%
- 5Y*
- -48.31%
- 10Y*
- —
SMHX
- 1D
- 5.94%
- 1M
- 31.13%
- YTD
- 76.78%
- 6M
- 74.71%
- 1Y
- 143.03%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
QNTM vs. SMHX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
QNTM Quantum BioPharma Ltd | -30.00% | 98.37% | -24.44% |
SMHX VanEck Fabless Semiconductor ETF | 76.78% | 30.00% | 17.76% |
Correlation
The correlation between QNTM and SMHX is 0.11, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.11 |
Correlation (All Time) Calculated using the full available price history since Aug 29, 2024 | 0.16 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
QNTM vs. SMHX — Risk / Return Rank
QNTM
SMHX
QNTM vs. SMHX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Quantum BioPharma Ltd (QNTM) and VanEck Fabless Semiconductor ETF (SMHX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| QNTM | SMHX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | -0.42 | 4.40 | -4.82 |
Sortino ratioReturn per unit of downside risk | 0.12 | 4.57 | -4.45 |
Omega ratioGain probability vs. loss probability | 1.01 | 1.60 | -0.59 |
Calmar ratioReturn relative to maximum drawdown | -0.66 | 8.64 | -9.30 |
Martin ratioReturn relative to average drawdown | -0.89 | 24.36 | -25.25 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| QNTM | SMHX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.42 | 4.40 | -4.82 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.36 | — | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.35 | 1.92 | -2.27 |
Drawdowns
QNTM vs. SMHX - Drawdown Comparison
The maximum QNTM drawdown since its inception was -99.98%, which is greater than SMHX's maximum drawdown of -38.53%. Use the drawdown chart below to compare losses from any high point for QNTM and SMHX.
Loading charts...
Drawdown Indicators
| QNTM | SMHX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -99.98% | -38.53% | -61.45% |
Max Drawdown (1Y)Largest decline over 1 year | -94.00% | -17.06% | -76.94% |
Max Drawdown (3Y)Largest decline over 3 years | -97.98% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -98.42% | — | — |
Current DrawdownCurrent decline from peak | -99.94% | 0.00% | -99.94% |
Average DrawdownAverage peak-to-trough decline | -92.22% | -7.35% | -84.87% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 69.73% | 6.05% | +63.68% |
Volatility
QNTM vs. SMHX - Volatility Comparison
Quantum BioPharma Ltd (QNTM) has a higher volatility of 54.60% compared to VanEck Fabless Semiconductor ETF (SMHX) at 12.04%. This indicates that QNTM's price experiences larger fluctuations and is considered to be riskier than SMHX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| QNTM | SMHX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 54.60% | 12.04% | +42.56% |
Volatility (6M)Calculated over the trailing 6-month period | 113.44% | 25.06% | +88.38% |
Volatility (1Y)Calculated over the trailing 1-year period | 160.28% | 32.72% | +127.56% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 134.24% | 40.01% | +94.23% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 140.72% | 40.01% | +100.71% |
Dividends
QNTM vs. SMHX - Dividend Comparison
QNTM has not paid dividends to shareholders, while SMHX's dividend yield for the trailing twelve months is around 0.01%.
| Position | TTM | 2025 | 2024 |
|---|---|---|---|
QNTM Quantum BioPharma Ltd | 0.00% | 0.00% | 0.00% |
SMHX VanEck Fabless Semiconductor ETF | 0.01% | 0.02% | 0.04% |
Frequently Asked Questions
QNTM and SMHX have a correlation of 0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
QNTM has higher volatility (54.60%) compared to SMHX (12.04%). In terms of maximum drawdown, QNTM dropped -99.98% vs SMHX's -38.53%.
SMHX currently has the higher Sharpe Ratio (4.40 vs -0.42), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for QNTM and SMHX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer